Financial Conflicts of Interest in Propensity Score-Matched Studies Evaluating Biologics and Biosimilars for Inflammatory Bowel Disease.
Karam ElsolhDaniel ThamMichael A ScaffidiNikko GimpayaRishi BansalNazi TorabiJuana LiYash VermaRishad KhanSamir C GroverPublished in: Journal of the Canadian Association of Gastroenterology (2022)
Overall, we found a high burden of undisclosed conflicts among authors of PSM studies comparing IBD biologics and biosimilars. Given the importance of PSM studies as a means for biologic comparison and the potential for undue industry influence from these payments, authors should ensure greater transparency with reporting of industry relationships.